For the year ending 2025-12-31, CLYM has $167,744K in assets. $7,269K in debts. $35,685K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 35,685 | |||
| Short-term marketable securities | 65,395 | |||
| Prepaid expenses and other current assets | 4,769 | |||
| Total current assets | 105,849 | |||
| Long-term marketable securities | 59,572 | |||
| Operating lease right-of-use assets | 505 | |||
| Property and equipment, net | 288 | |||
| Other long-term assets | 1,530 | |||
| Total assets | 167,744 | |||
| Accounts payable | 2,269 | |||
| Accrued expenses and other current liabilities | 4,459 | |||
| Operating lease liabilities | 256 | |||
| Total current liabilities | 6,984 | |||
| Operating lease liabilities, net of current portion | 285 | |||
| Total liabilities | 7,269 | |||
| Common stock, 0.0001 par value 250,000,000 shares authorized 47,766,338 and 67,255,434 shares issued and outstanding at december 31, 2025 and 2024, respectively | 5 | |||
| Additional paid-in capital | 449,762 | |||
| Accumulated other comprehensive income | 435 | |||
| Accumulated deficit | -289,727 | |||
| Total stockholders' equity | 160,475 | |||
| Total liabilities and stockholders' equity | 167,744 | |||
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)